What is malignant hyperthermia susceptibility?
British Journal of Anaesthesia · 2023
DOI: 10.1016/j.bja.2023.04.014 ↗Kurz gefasst
Editorial in der Zeitschrift British Journal of Anaesthesia, 2023. Verfasst von Philip M Hopkins. Beteiligte Einrichtung: Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK; Malignant Hyperthermia Investigation Unit, Department of Anaesthes…. Hauptthemen laut MEDLINE: Malignant Hyperthermia, Anesthesia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
The molecular mechanisms of susceptibility to malignant hyperthermia are complex. The malignant hyperthermia susceptibility phenotype should be reserved for patients who have a personal or family history consistent with malignant hyperthermia under anaesthesia and are subsequently demonstrated through diagnostic testing to be at risk.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Leeds Institute of Medical Research at St James's, University of Leeds, Leeds, UK; Malignant Hyperthermia Investigation Unit, Department of Anaesthesia, Leeds Teaching Hospitals NHS Trust, Leeds, UK. Electronic address:…
Zitieren
APA
Hopkins, P. M. (2023). What is malignant hyperthermia susceptibility?. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2023.04.014
Vancouver
Hopkins PM. What is malignant hyperthermia susceptibility?. British Journal of Anaesthesia. 2023. doi:10.1016/j.bja.2023.04.014
BibTeX
@article{Hopkins2023,
author = {Hopkins, Philip M},
title = {What is malignant hyperthermia susceptibility?},
journal = {British Journal of Anaesthesia},
year = {2023},
doi = {10.1016/j.bja.2023.04.014}
}
EUVIMED